Bright Minds Biosciences Inc 6-K, filed Oct 2, 2026
Bright Minds Biosciences Inc. (DRUG)
About this 6-K
Bright Minds Biosciences Inc filed this 6-K on October 2, 2026.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File No. 001-40997
BRIGHT MINDS BIOSCIENCES INC.
(Translation of registrant's name into English)
| 400 N Aberdeen St Suite 900 Chicago, IL 60642 (U.S. Corporate headquarters) |
1122 Mainland St #228 Vancouver, BC V6B 5L1 (Canadian Corporate headquarters) |
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F [ ] Form 40-F [ X ]
INCORPORATION BY REFERENCE
Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K are incorporated by reference into our (i) registration statement on Form F-3 (File No. 333-284694) filed on February 5, 2025, and (ii) registration statement on Form F-3 (File No. 333-289851) filed on August 26, 2025.
SUBMITTED HEREWITH
| Exhibits | |
| 99.1 | Report of Voting Results |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BRIGHT MINDS BIOSCIENCES INC.
"Ryan Cheung"
Ryan Cheung
Chief Financial Officer
Date: October 2, 2026
REPORT OF VOTING RESULTS
Pursuant to Section 11.3 of National Instrument 51-102 - Continuous Disclosure Obligations, the following is the report on voting results for the annual general meeting of shareholders of Bright Minds Biosciences Inc. ("the Company") held on March 31, 2026 (the "Meeting").
The Company reports that a total of 7,877,637 common shares were voted at the Meeting, representing 80.49% of the votes attached to the common shares outstanding as of the record date for the Meeting. Voting results on the resolutions were as follows:
1. Election of Directors
The six nominees for election to the Board of Directors received votes as follows.
| Nominee | Votes For | % Votes For | Votes Withheld | % Votes Withheld | ||||
| Ian McDonald | 7,564,151 | 99.99% | 492 | 0.01% | ||||
| Nils Bottler | 6,789,827 | 89.76% | 774,816 | 10.24% | ||||
| Jeremy Fryzuk | 7,384,419 | 97.62% | 180,224 | 2.38% | ||||
| Jan Pedersen | 6,995,861 | 92.48% | 568,782 | 7.52% | ||||
| David Weiner | 7,384,084 | 97.61% | 180,559 | 2.39% | ||||
| Steve Farr | 7,564,376 | 100.00% | 267 | 0.00% |
2. Appointment of Auditors
De Visser Gray LLP, Chartered Professional Accountants, were appointed as the auditor of the Company. Shares voted in person and by proxy represented 7,872,821 votes FOR, being 99.94% and 4,816 votes WITHHELD, being 0.06%.